SI0920302T2 - Farmacevtski aerosolni sestavek - Google Patents

Farmacevtski aerosolni sestavek

Info

Publication number
SI0920302T2
SI0920302T2 SI9830245T SI9830245T SI0920302T2 SI 0920302 T2 SI0920302 T2 SI 0920302T2 SI 9830245 T SI9830245 T SI 9830245T SI 9830245 T SI9830245 T SI 9830245T SI 0920302 T2 SI0920302 T2 SI 0920302T2
Authority
SI
Slovenia
Prior art keywords
aerosol composition
pharmaceutical aerosol
pharmaceutical
composition
aerosol
Prior art date
Application number
SI9830245T
Other languages
English (en)
Slovenian (sl)
Other versions
SI0920302T1 (en
Inventor
David Lewis
Davis Ganderton
Brian Meakin
Paolo Ventura
Gaetano Brambilla
Raffaella Garzia
Original Assignee
Chiesi Farma Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10814179&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI0920302(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chiesi Farma Spa filed Critical Chiesi Farma Spa
Publication of SI0920302T1 publication Critical patent/SI0920302T1/xx
Publication of SI0920302T2 publication Critical patent/SI0920302T2/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI9830245T 1997-06-13 1998-06-10 Farmacevtski aerosolni sestavek SI0920302T2 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9712434A GB2326334A (en) 1997-06-13 1997-06-13 Pharmaceutical aerosol compositions
EP98937474A EP0920302B2 (en) 1997-06-13 1998-06-10 Pharmaceutical aerosol composition
PCT/EP1998/003533 WO1998056349A1 (en) 1997-06-13 1998-06-10 Pharmaceutical aerosol composition

Publications (2)

Publication Number Publication Date
SI0920302T1 SI0920302T1 (en) 2002-12-31
SI0920302T2 true SI0920302T2 (sl) 2006-10-31

Family

ID=10814179

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9830245T SI0920302T2 (sl) 1997-06-13 1998-06-10 Farmacevtski aerosolni sestavek

Country Status (44)

Country Link
EP (2) EP0920302B2 (enExample)
JP (1) JP4380802B2 (enExample)
KR (1) KR100546239B1 (enExample)
CN (1) CN1138532C (enExample)
AR (1) AR012977A1 (enExample)
AT (1) ATE222751T1 (enExample)
AU (1) AU729966B2 (enExample)
BG (1) BG63906B1 (enExample)
BR (1) BR9805993B1 (enExample)
CA (1) CA2263445C (enExample)
CO (1) CO4940408A1 (enExample)
CZ (1) CZ295521B6 (enExample)
DE (1) DE69807420T3 (enExample)
DK (1) DK0920302T4 (enExample)
DZ (1) DZ2516A1 (enExample)
EA (1) EA001259B1 (enExample)
EE (1) EE03664B1 (enExample)
ES (1) ES2182351T5 (enExample)
GB (1) GB2326334A (enExample)
GE (1) GEP20012462B (enExample)
HR (1) HRP980317B1 (enExample)
HU (1) HU228487B1 (enExample)
ID (1) ID21491A (enExample)
IL (1) IL128484A (enExample)
IN (1) IN189317B (enExample)
IS (1) IS2435B (enExample)
IT (1) IT1293803B1 (enExample)
MA (1) MA26507A1 (enExample)
ME (2) ME00333B (enExample)
MY (1) MY119074A (enExample)
NO (1) NO327775B1 (enExample)
NZ (1) NZ334149A (enExample)
PL (1) PL193721B1 (enExample)
PT (1) PT920302E (enExample)
RS (1) RS51274B (enExample)
SA (1) SA98190821B1 (enExample)
SI (1) SI0920302T2 (enExample)
SK (1) SK284430B6 (enExample)
TN (1) TNSN98087A1 (enExample)
TR (1) TR199900288T1 (enExample)
TW (1) TW555570B (enExample)
UA (1) UA70289C2 (enExample)
WO (1) WO1998056349A1 (enExample)
ZA (1) ZA985136B (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
US6479035B1 (en) 1999-09-11 2002-11-12 Smithkline Beecham Corporation Pharmaceutical formulation of fluticasone propionate
ES2234694T3 (es) * 1999-11-23 2005-07-01 Glaxo Group Limited Formulaciones farmaceuticas de salmeterol.
WO2001047493A1 (en) * 1999-12-24 2001-07-05 Glaxo Group Limited Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
IT1317846B1 (it) * 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
IT1318514B1 (it) * 2000-05-12 2003-08-27 Chiesi Farma Spa Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
HU230804B1 (hu) 2000-05-22 2018-06-28 Chiesi Farmaceutici S.P.A Gyógyászati célú stabil aeroszol összetétel, inhalátor az aeroszol pontos adagolásához és eljárás ennek feltöltésére
WO2002072067A2 (en) * 2001-03-12 2002-09-19 Glaxo Group Limited Pharmaceutical aerosol formulation
ATE267591T1 (de) 2001-07-02 2004-06-15 Chiesi Farma Spa Optimierte tobramycin-formulierung zur aerosolbildung
EP1340503A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Solution aerosol formulation containing esters of 3, 17-dihydroxy oestratriene derivates for pulmonary delivery
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
LT3384931T (lt) 2002-03-01 2019-09-25 Chiesi Farmaceutici S.P.A. Ypatingai smulki formoterolio kompozicija
DE10214263A1 (de) * 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
EP1369113B1 (en) * 2002-06-06 2006-11-22 CHIESI FARMACEUTICI S.p.A. Solubilisation of drugs in HFA propellant by means of emulsions
JP2006516545A (ja) * 2003-02-04 2006-07-06 クリサリス テクノロジーズ インコーポレイテッド パーフルオロカーボン及びハイドロフルオロカーボン製剤及びその製法及び使用法
JP4708332B2 (ja) 2003-03-20 2011-06-22 ベーリンガー インゲルハイム ファーマシューティカルズ インコーポレイテッド 推進剤としてヒドロフルオロアルカンを用いる計量式吸入器のための調合物
EP1915985A1 (en) * 2003-03-20 2008-04-30 Boehringer Ingelheim Pharmaceuticals Inc. Formulation for a Metered Dose Inhaler Using Hydro-Fluoro-Alkanes as Propellants
SE0303179D0 (sv) * 2003-11-26 2003-11-26 Astrazeneca Ab Novel compounds
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
CA2571519C (en) 2004-07-02 2013-05-14 Boehringer Ingelheim International Gmbh Aerosol suspension formulations containing tg 227 ea or tg 134 a as a propellant
DE102006017320A1 (de) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
GB0621707D0 (en) * 2006-10-31 2006-12-13 Univ London Pharmacy Formulations for delivery via pressurised metered dose inhalers
GB0712454D0 (en) 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
EP2217278A1 (en) * 2007-11-07 2010-08-18 AstraZeneca AB Dry powder formulations comprising ascorbic acid derivates
CN105854136A (zh) * 2010-09-06 2016-08-17 奇斯药制品公司 计量剂量吸入器和使用该计量剂量吸入器的方法
JP5409594B2 (ja) * 2010-12-22 2014-02-05 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧式定量吸入器のための安定な製薬学的溶液製剤
JP6335798B2 (ja) 2012-02-28 2018-05-30 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 新規噴射剤含有チオトロピウム製剤
RU2504402C1 (ru) * 2012-11-20 2014-01-20 Шолекс Девелопмент Гмбх Ингаляционный состав в форме аэрозоля для лечения бронхиальной астмы и хронической обструктивной болезни легких
GB201402513D0 (en) 2014-02-13 2014-04-02 Cardiff Scintigraphics Ltd Pressurised metered dose inhalers and method of manufacture
EP3174522A1 (en) 2014-07-29 2017-06-07 3M Innovative Properties Company Method of preparing a pharmaceutical composition
WO2017167737A1 (en) 2016-03-31 2017-10-05 Chiesi Farmaceutici S.P.A. Aerosol inhalation device
IL265349B2 (en) * 2016-09-19 2023-03-01 Mexichem Fluor Sa De Cv Pharmaceutical composition
WO2025039045A1 (en) * 2023-08-23 2025-02-27 Inhaler Supplies Pty Ltd Inhalable formulation for volatile actives

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE71520T1 (de) † 1986-03-10 1992-02-15 Burghart Kurt Pharmazeutische zubereitung sowie verfahren zur herstellung derselben.
EP0259383B1 (de) † 1986-03-10 1991-01-23 Kurt Dr. Burghart Pharmazeutikum sowie verfahren zu seiner herstellung
US4899874A (en) † 1988-04-26 1990-02-13 Rehrig-Pacific Company, Inc. Stackable low depth bottle case
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5225183A (en) † 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
DE3905726A1 (de) * 1989-02-24 1990-08-30 Hoechst Ag Druckgaspackung und treibmittel fuer aerosole
CA2094266C (en) † 1990-10-18 1999-06-01 Robert K. Schultz Aerosol formulations of beclomethasone-17,21-dipropionate
GB9024365D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
CA2111002C (en) † 1991-06-10 2000-08-22 Julianne Fassberg Non-chlorofluorocarbon aerosol formulations
IL102130A0 (en) † 1991-06-10 1993-01-14 Schering Corp Non-chlorofluorocarbon aerosol formulations
DE4123663A1 (de) * 1991-07-17 1993-01-21 Schwabe Willmar Gmbh & Co Aerosol-zubereitung und verwendung eines treibmittels dafuer
DE4123668A1 (de) * 1991-07-17 1993-01-21 Rovema Gmbh Verfahren und vorrichtung zur zufuehrung von folienmaterial zu einer intermittierend arbeitenden schlauchbeutelmaschine
DK0616525T3 (da) * 1991-12-12 1996-01-08 Glaxo Group Ltd Medikamenter
ATE204743T1 (de) * 1991-12-18 2001-09-15 Minnesota Mining & Mfg Aerosolzusammensetzungen für arzneimittelsuspensionen
RO117414B1 (ro) * 1992-12-09 2002-03-29 Jager Paul D Waterbury Compozitie farmaceutica de aerosol in solutie
US5502076A (en) * 1994-03-08 1996-03-26 Hoffmann-La Roche Inc. Dispersing agents for use with hydrofluoroalkane propellants
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
US5534242A (en) † 1994-05-02 1996-07-09 Henry; Richard A. Lidocaine-vasoconstrictor aerosol preparation
JP3911290B2 (ja) † 1994-05-13 2007-05-09 アラダイム コーポレーション エアゾールを含む麻酔用処方
US5653961A (en) † 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
US5635161A (en) † 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils
GB9517998D0 (en) † 1995-09-04 1995-11-08 Bioglan Lab Ltd Compositions and device for their administration
JP2000514085A (ja) * 1996-07-08 2000-10-24 ローヌ―プーラン・ロウラー・リミテッド 医薬シクロスポリンａエーロゾル溶液処方物
ES2244008T3 (es) † 1996-12-04 2005-12-01 Link Products Limited Composiciones farmaceuticas y dispositivos para su administracion.
PT1014943E (pt) † 1997-02-05 2002-11-29 Jago Res Ag Formulacoes medicinais de aerossois

Also Published As

Publication number Publication date
PT920302E (pt) 2002-11-29
KR20000068171A (ko) 2000-11-25
CN1138532C (zh) 2004-02-18
TR199900288T1 (xx) 1999-09-21
EE03664B1 (et) 2002-04-15
EA199900201A1 (ru) 1999-06-24
HUP0001339A3 (en) 2000-10-30
DK0920302T4 (da) 2006-10-09
DK0920302T3 (da) 2002-12-23
GEP20012462B (en) 2001-06-25
GB2326334A (en) 1998-12-23
NO990594L (no) 1999-04-13
CA2263445A1 (en) 1998-12-17
ES2182351T5 (es) 2007-03-16
EP0920302B1 (en) 2002-08-28
CZ46299A3 (cs) 1999-07-14
AR012977A1 (es) 2000-11-22
CA2263445C (en) 2008-09-09
TW555570B (en) 2003-10-01
HRP980317B1 (en) 2002-06-30
ITMI971798A1 (it) 1999-01-28
CZ295521B6 (cs) 2005-08-17
NZ334149A (en) 2000-07-28
EE9900055A (et) 1999-08-16
KR100546239B1 (ko) 2006-01-26
BG103221A (en) 1999-09-30
RS51274B (sr) 2010-12-31
EP1219293A2 (en) 2002-07-03
EP0920302B2 (en) 2006-06-21
EP0920302A1 (en) 1999-06-09
YU6999A (sh) 2000-03-21
EP1219293A3 (en) 2003-05-28
DE69807420T2 (de) 2003-05-08
DE69807420D1 (de) 2002-10-02
PL331531A1 (en) 1999-07-19
SK17699A3 (en) 1999-07-12
SK284430B6 (sk) 2005-04-01
ME00333B (me) 2011-02-10
BR9805993A (pt) 1999-08-31
EA001259B1 (ru) 2000-12-25
NO327775B1 (no) 2009-09-21
DE69807420T3 (de) 2006-11-16
TNSN98087A1 (fr) 2005-03-15
SI0920302T1 (en) 2002-12-31
ID21491A (id) 1999-06-17
IL128484A0 (en) 2000-01-31
ZA985136B (en) 1999-01-07
MA26507A1 (fr) 2004-12-20
ES2182351T3 (es) 2003-03-01
PL193721B1 (pl) 2007-03-30
AU729966B2 (en) 2001-02-15
IS2435B (is) 2008-10-15
DZ2516A1 (fr) 2004-11-08
JP2000516965A (ja) 2000-12-19
HRP980317A2 (en) 1999-04-30
CO4940408A1 (es) 2000-07-24
CN1229355A (zh) 1999-09-22
HU228487B1 (en) 2013-03-28
AU8626298A (en) 1998-12-30
BR9805993B1 (pt) 2009-05-05
JP4380802B2 (ja) 2009-12-09
HUP0001339A2 (hu) 2000-09-28
UA70289C2 (uk) 2004-10-15
IL128484A (en) 2004-09-27
NO990594D0 (no) 1999-02-09
IS4974A (is) 1999-02-11
WO1998056349A1 (en) 1998-12-17
IN189317B (enExample) 2003-02-08
ATE222751T1 (de) 2002-09-15
MEP44008A (en) 2011-02-10
IT1293803B1 (it) 1999-03-10
HK1022271A1 (en) 2000-08-04
GB9712434D0 (en) 1997-08-13
SA98190821B1 (ar) 2006-11-19
MY119074A (en) 2005-03-31
BG63906B1 (bg) 2003-06-30

Similar Documents

Publication Publication Date Title
HRP980317B1 (en) Pharmaceutical aerosol composition
IL139087A0 (en) Pharmaceutical aerosol formulation
GB9706089D0 (en) Pharmaceutical composition
GB9727053D0 (en) Pharmaceutical compositions
IL133928A0 (en) Pharmaceutical composition containing peptichemio
GB9717444D0 (en) Pharmaceutical composition
HUP0002455A3 (en) Gastric-retained pharmaceutical composition
AP9901657A0 (en) Pharmaceutical compositions
GB9717428D0 (en) Pharmaceutical composition
GB9723985D0 (en) Pharmaceutical compositions
HUP0004669A3 (en) Pharmaceutical compositions
HU9700632D0 (en) Pharmaceutical compositions
GB9717770D0 (en) Pharmaceutical composition
GB2321190B (en) Pharmaceutical composition
GB9921495D0 (en) Pharmaceutical compositions
GB9726781D0 (en) Pharmaceutical composition
GB9718270D0 (en) Pharmaceutical compositions
HU9701598D0 (en) Pharmaceutical composition
GB9717575D0 (en) Pharmaceutical composition
GB9710525D0 (en) Pharmaceutical composition
GB9702517D0 (en) Pharmaceutical composition
ZA981391B (en) Pharmaceutical composition
GB9710632D0 (en) Pharmaceutical composition
GB9727238D0 (en) Pharmaceutical composition
GB9712097D0 (en) Pharmaceutical composition